Literature DB >> 20439981

Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses.

Adrienne R Trombley1, Leslie Wachter, Jeffrey Garrison, Valerie A Buckley-Beason, Jordan Jahrling, Lisa E Hensley, Randal J Schoepp, David A Norwood, Augustine Goba, Joseph N Fair, David A Kulesh.   

Abstract

Viral hemorrhagic fever is caused by a diverse group of single-stranded, negative-sense or positive-sense RNA viruses belonging to the families Filoviridae (Ebola and Marburg), Arenaviridae (Lassa, Junin, Machupo, Sabia, and Guanarito), and Bunyaviridae (hantavirus). Disease characteristics in these families mark each with the potential to be used as a biological threat agent. Because other diseases have similar clinical symptoms, specific laboratory diagnostic tests are necessary to provide the differential diagnosis during outbreaks and for instituting acceptable quarantine procedures. We designed 48 TaqMan-based polymerase chain reaction (PCR) assays for specific and absolute quantitative detection of multiple hemorrhagic fever viruses. Forty-six assays were determined to be virus-specific, and two were designated as pan assays for Marburg virus. The limit of detection for the assays ranged from 10 to 0.001 plaque-forming units (PFU)/PCR. Although these real-time hemorrhagic fever virus assays are qualitative (presence of target), they are also quantitative (measure a single DNA/RNA target sequence in an unknown sample and express the final results as an absolute value (e.g., viral load, PFUs, or copies/mL) on the basis of concentration of standard samples and can be used in viral load, vaccine, and antiviral drug studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20439981      PMCID: PMC2861391          DOI: 10.4269/ajtmh.2010.09-0636

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  22 in total

1.  Development and evaluation of a fluorogenic 5'-nuclease assay to identify Marburg virus.

Authors:  T R Gibb; D A Norwood; N Woollen; E A Henchal
Journal:  Mol Cell Probes       Date:  2001-10       Impact factor: 2.365

2.  Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations.

Authors:  D G Bausch; A H Demby; M Coulibaly; J Kanu; A Goba; A Bah; N Condé; H L Wurtzel; K F Cavallaro; E Lloyd; F B Baldet; S D Cissé; D Fofona; I K Savané; R T Tolno; B Mahy; K D Wagoner; T G Ksiazek; C J Peters; P E Rollin
Journal:  Vector Borne Zoonotic Dis       Date:  2001       Impact factor: 2.133

3.  Highly sensitive Taqman PCR detection of Puumala hantavirus.

Authors:  D Garin; C Peyrefitte; J M Crance; A Le Faou; A Jouan; M Bouloy
Journal:  Microbes Infect       Date:  2001-07       Impact factor: 2.700

4.  Rapid detection of human pathogenic orthobunyaviruses.

Authors:  Manfred Weidmann; Veronique Rudaz; Marcio R T Nunes; Pedro F C Vasconcelos; Frank T Hufert
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

5.  Rapid detection protocol for filoviruses.

Authors:  Manfred Weidmann; Elke Mühlberger; Frank T Hufert
Journal:  J Clin Virol       Date:  2004-05       Impact factor: 3.168

6.  A prospective study of the epidemiology and ecology of Lassa fever.

Authors:  J B McCormick; P A Webb; J W Krebs; K M Johnson; E S Smith
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

7.  Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR.

Authors:  Christian Drosten; Stephan Göttig; Stefan Schilling; Marcel Asper; Marcus Panning; Herbert Schmitz; Stephan Günther
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

8.  Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels.

Authors:  Anthony Sanchez; Matthew Lukwiya; Daniel Bausch; Siddhartha Mahanty; Angela J Sanchez; Kent D Wagoner; Pierre E Rollin
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome.

Authors:  Jonathan S Towner; Pierre E Rollin; Daniel G Bausch; Anthony Sanchez; Sharon M Crary; Martin Vincent; William F Lee; Christina F Spiropoulou; Thomas G Ksiazek; Mathew Lukwiya; Felix Kaducu; Robert Downing; Stuart T Nichol
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

10.  Persistent Sin Nombre virus infection in the deer mouse (Peromyscus maniculatus) model: sites of replication and strand-specific expression.

Authors:  Jason Botten; Katy Mirowsky; Donna Kusewitt; Chunyan Ye; Keith Gottlieb; Joseph Prescott; Brian Hjelle
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

View more
  109 in total

Review 1.  Laboratory Diagnosis of Lassa Fever.

Authors:  Vanessa Raabe; Jeffrey Koehler
Journal:  J Clin Microbiol       Date:  2017-04-12       Impact factor: 5.948

2.  Particle-to-PFU ratio of Ebola virus influences disease course and survival in cynomolgus macaques.

Authors:  Kendra J Alfson; Laura E Avena; Michael W Beadles; Hilary Staples; Jerritt W Nunneley; Anysha Ticer; Edward J Dick; Michael A Owston; Christopher Reed; Jean L Patterson; Ricardo Carrion; Anthony Griffiths
Journal:  J Virol       Date:  2015-07       Impact factor: 5.103

3.  Anti-Ebola Virus Antibody Levels in Convalescent Plasma and Viral Load After Plasma Infusion in Patients With Ebola Virus Disease.

Authors:  Jerry F Brown; John M Dye; Sam Tozay; Gertrude Jeh-Mulbah; David A Wohl; William A Fischer; Coleen K Cunningham; Kathleen Rowe; Peter Zacharias; James van Hasselt; David A Norwood; Nathan M Thielman; Samantha E Zak; David L Hoover
Journal:  J Infect Dis       Date:  2018-07-13       Impact factor: 5.226

4.  Buffer AVL Alone Does Not Inactivate Ebola Virus in a Representative Clinical Sample Type.

Authors:  Sophie J Smither; Simon A Weller; Amanda Phelps; Lin Eastaugh; Sarah Ngugi; Lyn M O'Brien; Jackie Steward; Steve G Lonsdale; Mark S Lever
Journal:  J Clin Microbiol       Date:  2015-07-15       Impact factor: 5.948

5.  Protocadherin-1 is essential for cell entry by New World hantaviruses.

Authors:  Rohit K Jangra; Andrew S Herbert; Rong Li; Lucas T Jae; Lara M Kleinfelter; Megan M Slough; Sarah L Barker; Pablo Guardado-Calvo; Gleyder Román-Sosa; M Eugenia Dieterle; Ana I Kuehne; Nicolás A Muena; Ariel S Wirchnianski; Elisabeth K Nyakatura; J Maximilian Fels; Melinda Ng; Eva Mittler; James Pan; Sushma Bharrhan; Anna Z Wec; Jonathan R Lai; Sachdev S Sidhu; Nicole D Tischler; Félix A Rey; Jason Moffat; Thijn R Brummelkamp; Zhongde Wang; John M Dye; Kartik Chandran
Journal:  Nature       Date:  2018-11-21       Impact factor: 49.962

Review 6.  Strategies in Ebola virus disease (EVD) diagnostics at the point of care.

Authors:  Chad T Coarsey; Nwadiuto Esiobu; Ramswamy Narayanan; Mirjana Pavlovic; Hadi Shafiee; Waseem Asghar
Journal:  Crit Rev Microbiol       Date:  2017-04-25       Impact factor: 7.624

7.  Development, Evaluation, and Integration of a Quantitative Reverse-Transcription Polymerase Chain Reaction Diagnostic Test for Ebola Virus on a Molecular Diagnostics Platform.

Authors:  Lieselotte Cnops; Peter Van den Eede; James Pettitt; Leo Heyndrickx; Birgit De Smet; Sandra Coppens; Ilse Andries; Theresa Pattery; Luc Van Hove; Geert Meersseman; Sari Van Den Herrewegen; Nicolas Vergauwe; Rein Thijs; Peter B Jahrling; David Nauwelaers; Kevin K Ariën
Journal:  J Infect Dis       Date:  2016-05-30       Impact factor: 5.226

8.  Multiplexed efficient on-chip sample preparation and sensitive amplification-free detection of Ebola virus.

Authors:  K Du; H Cai; M Park; T A Wall; M A Stott; K J Alfson; A Griffiths; R Carrion; J L Patterson; A R Hawkins; H Schmidt; R A Mathies
Journal:  Biosens Bioelectron       Date:  2017-01-03       Impact factor: 10.618

9.  Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection.

Authors:  Matthew L Boisen; Robert W Cross; Jessica N Hartnett; Augustine Goba; Mambu Momoh; Mohamed Fullah; Michael Gbakie; Sidiki Safa; Mbalu Fonnie; Francis Baimba; Veronica J Koroma; Joan B Geisbert; Stephanie McCormick; Diana K S Nelson; Molly M Millett; Darin Oottamasathien; Abby B Jones; Ha Pham; Bethany L Brown; Jeffrey G Shaffer; John S Schieffelin; Brima Kargbo; Momoh Gbetuwa; Sahr M Gevao; Russell B Wilson; Kelly R Pitts; Thomas W Geisbert; Luis M Branco; Sheik H Khan; Donald S Grant; Robert F Garry
Journal:  J Infect Dis       Date:  2016-08-11       Impact factor: 5.226

10.  Lateral Flow Immunoassays for Ebola Virus Disease Detection in Liberia.

Authors:  Jill C Phan; James Pettitt; Josiah S George; Lawrence S Fakoli; Fahn M Taweh; Stacey L Bateman; Richard S Bennett; Sarah L Norris; David A Spinnler; Guillermo Pimentel; Phillip K Sahr; Fatorma K Bolay; Randal J Schoepp
Journal:  J Infect Dis       Date:  2016-07-20       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.